Tesofensine

A triple monoamine reuptake inhibitor; blocks reuptake of serotonin, norepinephrine, and dopamine to suppress appetite and modestly raise energy expenditure.

Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.

Studied for obesity and weight loss, typically as a fixed-dose combination with the beta-blocker metoprolol (Tesomet) to offset cardiovascular effects.

• Weight & metabolicStudied in weight, appetite, blood-sugar, and fat-metabolism research.
• Cognitive & moodStudied in memory, focus, mood, and neuroprotection research.

In clinical trials outside the US; Phase 3 ongoing for the Tesomet combination, but there is no active US Phase 3 program and it is not FDA-approved.

Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.

• Independent purity. Look for a third-party COA (Janoshik or MZ) showing a measured purity — not just a number the vendor typed.
• Batch match. The strongest evidence is a certificate for the exact batch you’ll receive, attributed to this vendor — check the cross-verification on the listing.
• Vendor reputation. See how the vendor is talked about in the community before trusting a new name.

Research context only — VialGrade never gives dosing, medical, or human-use guidance.